BRPI0412832A - uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas - Google Patents
uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanasInfo
- Publication number
- BRPI0412832A BRPI0412832A BRPI0412832-0A BRPI0412832A BRPI0412832A BR PI0412832 A BRPI0412832 A BR PI0412832A BR PI0412832 A BRPI0412832 A BR PI0412832A BR PI0412832 A BRPI0412832 A BR PI0412832A
- Authority
- BR
- Brazil
- Prior art keywords
- yessotoxins
- inhibitors
- cell growth
- tumor cell
- therapeutic use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
"USO TERAPêUTICO DAS YESSOTOXINAS COMO INIBIDORES DO CRESCIMENTO DE CéLULAS TUMORAIS HUMANAS". O Uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas. O mecanismo de ação da yessotoxina (YTX) e de análogos está relacionado à ativação das fosfodiesterases celulares e, como conseqüência, à diminuição dos níveis citossólicos de AMPc. O resultado desta ativação, depois da administração de YTX, é uma inibição do crescimento de células de hepatocarcinoma humano. Este efeito citotóxico da YTX sobre células neoplásicas pode ser utilizado como estratégia para o desenvolvimento de fármacos úteis no tratamento de processos tumorais.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200301773A ES2235611B2 (es) | 2003-07-25 | 2003-07-25 | Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas. |
PCT/ES2004/000343 WO2005012543A2 (es) | 2003-07-25 | 2004-07-21 | Método cuantitativo para la detección de yesotoxinas en productos pesqueros basado en la activación que la toxina produce en las fosfodiesterasas celulares y utilidad terapéutica de esta activación. |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0412832A true BRPI0412832A (pt) | 2006-11-21 |
Family
ID=34112518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0412832-0A BRPI0412832A (pt) | 2003-07-25 | 2004-07-21 | uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas |
Country Status (12)
Country | Link |
---|---|
US (1) | US20110065138A1 (pt) |
EP (3) | EP1875907B1 (pt) |
JP (2) | JP2006528483A (pt) |
CN (1) | CN1852988A (pt) |
AT (3) | ATE524174T1 (pt) |
AU (3) | AU2004260895A1 (pt) |
BR (1) | BRPI0412832A (pt) |
CA (1) | CA2533600A1 (pt) |
DE (1) | DE602004013446D1 (pt) |
ES (4) | ES2235611B2 (pt) |
RU (1) | RU2389488C2 (pt) |
WO (1) | WO2005012543A2 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101382531B (zh) * | 2008-10-08 | 2011-12-28 | 天津商业大学 | 利用电子鼻检测虾新鲜度的方法 |
ES2393696B2 (es) * | 2012-09-07 | 2013-06-04 | Universidade De Santiago De Compostela | Uso de la Yessotoxina y sus derivados para el tratamiento de gliomas |
CN105198900A (zh) * | 2015-09-22 | 2015-12-30 | 国家海洋环境检测中心 | 虾夷扇贝毒素ytx纯品的提取、制备方法 |
US10890573B2 (en) | 2017-12-19 | 2021-01-12 | International Business Machines Corporation | Facile methods to detect toxin in seafood |
RU2716233C1 (ru) * | 2018-11-13 | 2020-03-10 | Федеральное государственное бюджетное учреждение науки "Федеральный исследовательский центр питания, биотехнологии и безопасности пищи" | Способ количественного определения йессотоксинов в моллюсках |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672509A (en) * | 1993-08-25 | 1997-09-30 | Pfizer Inc. | hPDE IV-C: a human phosphodiesterase IV isozyme |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
AU3635099A (en) * | 1997-12-15 | 1999-07-26 | Beth Israel Deaconess Medical Center | Methods and reagents for modulating cell motility |
IT1318605B1 (it) | 2000-06-30 | 2003-08-27 | Uni Degli Studi Di Modena E Re | Procedimoento per il dosaggio di tossine dsp del gruppo delledinophysitossine e delle yessottossine. |
US6977155B2 (en) * | 2000-08-10 | 2005-12-20 | Corning Incorporated | Arrays of biological membranes and methods and use thereof |
EP1251181A1 (en) * | 2001-04-20 | 2002-10-23 | Warner-Lambert Company | Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phosphodiesterase 4 (PDE4) subtype B and their use for the screening of PDE4 subtype-specific modulators |
-
2003
- 2003-07-25 ES ES200301773A patent/ES2235611B2/es not_active Expired - Fee Related
-
2004
- 2004-07-21 AU AU2004260895A patent/AU2004260895A1/en not_active Abandoned
- 2004-07-21 CN CNA200480021338XA patent/CN1852988A/zh active Pending
- 2004-07-21 BR BRPI0412832-0A patent/BRPI0412832A/pt not_active Application Discontinuation
- 2004-07-21 CA CA002533600A patent/CA2533600A1/en not_active Abandoned
- 2004-07-21 EP EP07017631A patent/EP1875907B1/en not_active Not-in-force
- 2004-07-21 WO PCT/ES2004/000343 patent/WO2005012543A2/es active IP Right Grant
- 2004-07-21 RU RU2006101631/15A patent/RU2389488C2/ru not_active IP Right Cessation
- 2004-07-21 EP EP07017630A patent/EP1875906B1/en not_active Not-in-force
- 2004-07-21 AT AT07017631T patent/ATE524174T1/de not_active IP Right Cessation
- 2004-07-21 ES ES07017630T patent/ES2368872T3/es active Active
- 2004-07-21 US US10/566,050 patent/US20110065138A1/en not_active Abandoned
- 2004-07-21 AT AT04742071T patent/ATE393833T1/de not_active IP Right Cessation
- 2004-07-21 EP EP04742071A patent/EP1647599B1/en active Active
- 2004-07-21 JP JP2006520848A patent/JP2006528483A/ja active Pending
- 2004-07-21 DE DE602004013446T patent/DE602004013446D1/de active Active
- 2004-07-21 AT AT07017630T patent/ATE514423T1/de not_active IP Right Cessation
- 2004-12-10 ES ES200402943A patent/ES2259266B2/es not_active Expired - Fee Related
- 2004-12-10 ES ES200402944A patent/ES2259894B2/es not_active Expired - Fee Related
-
2006
- 2006-03-27 JP JP2006084989A patent/JP2006325580A/ja active Pending
-
2010
- 2010-05-31 AU AU2010202237A patent/AU2010202237A1/en not_active Abandoned
- 2010-05-31 AU AU2010202232A patent/AU2010202232A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1647599B1 (en) | 2008-04-30 |
JP2006325580A (ja) | 2006-12-07 |
EP1875907A2 (en) | 2008-01-09 |
JP2006528483A (ja) | 2006-12-21 |
CN1852988A (zh) | 2006-10-25 |
EP1875906A2 (en) | 2008-01-09 |
ES2259894B2 (es) | 2008-11-16 |
ES2259894A1 (es) | 2006-10-16 |
ES2368872T3 (es) | 2011-11-23 |
EP1875906A3 (en) | 2008-02-27 |
US20110065138A1 (en) | 2011-03-17 |
ATE524174T1 (de) | 2011-09-15 |
WO2005012543A2 (es) | 2005-02-10 |
EP1875906B1 (en) | 2011-06-29 |
AU2010202237A1 (en) | 2010-06-24 |
RU2389488C2 (ru) | 2010-05-20 |
AU2010202232A1 (en) | 2010-07-08 |
DE602004013446D1 (de) | 2008-06-12 |
CA2533600A1 (en) | 2005-02-10 |
ES2259266A1 (es) | 2006-09-16 |
EP1875907A3 (en) | 2008-02-27 |
RU2006101631A (ru) | 2006-08-27 |
ES2259266B2 (es) | 2008-06-01 |
ATE393833T1 (de) | 2008-05-15 |
ES2235611B2 (es) | 2006-07-16 |
EP1875907B1 (en) | 2011-09-14 |
ATE514423T1 (de) | 2011-07-15 |
WO2005012543A3 (es) | 2005-03-17 |
EP1647599A2 (en) | 2006-04-19 |
ES2235611A1 (es) | 2005-07-01 |
AU2004260895A1 (en) | 2005-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201903587T4 (tr) | Telomeraz aktivitesinin artırılması için bileşimler. | |
EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии | |
DK1496895T3 (da) | Anvendelse af cyclopamin til behandling af psoriasis og andre hudlidelser | |
NO20072548L (no) | Xantinderivater med HM74A reseptoraktivitet | |
BRPI0412314B8 (pt) | composto 3-[2(r)-{hidroxicarbonilpropil-amino}-2-feniletil]-5-(2-flúor-3-metoxifenil)-1-[2-flúor-6-(trifluorometil)benzil]-6-metil-pirimidina-2,4(1h,3h)-diona, composição farmacêutica compreendendo dito composto e uso do mesmo para o tratamento de uma condição relacionada ao hormônio sexual | |
DE602005009318D1 (de) | Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren | |
AR071609A1 (es) | Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1 | |
CU23423B7 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea | |
EA200601747A1 (ru) | Три(цикло)замещённые амидные соединения | |
DE50208008D1 (de) | Tiotropiumsalze zur behandlung von entzündlichen erkrankungen | |
NO20064365L (no) | Terapeutisk forbindelse | |
UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
WO2002091999A3 (en) | Treatment for wounds | |
EA200970110A1 (ru) | Производные 6,9-дизамещённого пурина и их применение для лечения кожи | |
NO20083005L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av smerte | |
ATE413392T1 (de) | Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren | |
EA200970294A1 (ru) | Способ наращивания стволовых клеток взрослого организма из крови, в частности периферической, и соответственное применение в области медицины | |
CY1109763T1 (el) | Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης | |
NO20041059L (no) | Kombinasjon av utvalgte opioder med muskarinantagonister for behandling av urininkontinens | |
DE602006011959D1 (de) | Na+, k+-atpase-expression bei zervixdysplasie und -krebs | |
ATE556134T1 (de) | Mesenchymstammzellen und verwendungendafür | |
BRPI0412832A (pt) | uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas | |
BR112012016128A8 (pt) | Agente terapêutico (y-39983) para disfunção endotelial da córnea | |
BRPI0511125A (pt) | usos de ácido 5,6,7-triidroxieptanóico seus e análogos | |
EA200600468A1 (ru) | Биполярные транс-каротиноидные соли и их применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |